Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of Epi proColon in Repeated Testing in the Intended Use Population (PERT)

NCT03218423 is registered in ClinicalTrials.gov with Epigenomics, Inc as lead sponsor.

NCT NCT03218423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03218423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of Epi proColon in Repeated Testing in the Intended Use Population (PERT)
Lead sponsor
Epigenomics, Inc
Phase
Observational
Overall status
Unknown status
Start date
August 18, 2017
Completion date
January 31, 2024
Enrollment
4,500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, colorectal neoplasms